The effect of atorvastatin on Covid 19

Phase 3

• Conditions: Covid-19.; Coronavirus infection, unspecified; B34.2

• Registration Number: IRCT20210426051090N1
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 June 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients with confirmed molecular test of blood oxygen saturation level SpO2 less than 90% in room air
Patients with pulmonary involvement in radiological studies
Do not take statins
The patient is not in a state of shock and sepsis

Exclusion Criteria

Having advanced heart disease (CHF)
Liver disease (based on primary LFT)
Incidence of statin side effects
Long-term use of corticosteroids
to die
Pulmonary underlying disease

Study & Design

• Study Type: interventional
• Study Design: Not specified